Intravenous Solutions Market: Global Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis (2017-2021) and Forecast (2022-2028)

$ PRICE - $ 3,000.00$ 8,900.00

Intravenous Solutions Market: By Solution Type(Normal Saline (0.9% NaCl), Hypertonic Saline, Dextran, Lactated Ringer’s, Amino Acid, Vitamins & Minerals, Heparin and Trace Elements, Mixed Solutions), By Bag Type(Large Volume Bags, Small Volume Bags),By Application (Basic IV Solution, Nutritional IV Solution, Blood IV Solution, Drug IV Solution, Irrigation IV Solution),By End-user(Hospitals, Clinics, Ambulatory Surgery Centers and Home Care Settings), and Geography.

$ PRICE - $ 3,000.00$ 8,900.00
Clear selection
Clear
$ PRICE - $ 3,000.00$ 8,900.00
FacebookTwitterLinkedinEmail
SKU: N/A Category:

Report

Description

Intravenous Solutions Market size was valued at USD 11.5 billion in 2021. It is expected to reach a value of USD 19.6 billion by 2028, growing at a CAGR of 7.9% during the forecast period from 2022 to 2028. The global market provides a detailed overview which has been segmented by solution type, bag type, application, and end user. By solution type, the intravenous solutions market has been segmented into Normal Saline (0.9% NaCl), Hypertonic Saline, Dextran, Lactated Ringer, Amino Acids, Vitamins and Minerals, Heparin and Trace Elements, and Mixed Solutions. The amino acid segment is likely the most significant and fastest-growing segment in terms of solution type. By Bag Type, the intravenous solutions market has been segmented into Large Volume Bags, Small Volume Bags. The small-volume bags segment gains the maximum revenue share in the market. By application, the intravenous solutions market has been segmented into Basic IV Solution, Nutritional IV Solution, Blood IV Solution, Drug IV Solution, and Irrigation IV Solution. The nutritional IV solution segment dominated the market in the forecast period 2022-2028. Based on the end user, the Intravenous Solutions are segmented into Hospitals, Clinics, Ambulatory Surgery Centers, and Home Care Settings. According to precision business insights, the hospital segment is predicted to register the fastest growth rate during the forecast period.

Key Development:

In February 2022, B. Braun Medical received the US FDA approval to begin operations at its new IV saline solution manufacturing facility in Daytona Beach, Florida.

Intravenous Solutions Market

MARKET SUMMARY
-
7.9%
  • Study Period– 2022 – 2028
  • Base Year– 2021
  • CAGR– 7.9%
  • Largest Market– Asia Pacific
  • Fastest Growing Market– North America

Intravenous Solutions Market

  • The global intravenous solutions market report gives a comprehensive outlook across the globe with special emphasis on key regions such as North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa.
  • The report on the global  intravenous solutions market gives historical, current, and future market sizes (US$ Mn) on the basis of  solution type, bag type, application and region.
Key Players
  • Baxter International Inc.
  • ICU Medical, Inc.
  • B. Braun Melsungen Ag
  • Fresenius Kabi USA, LLC
  • Vifor Pharma Management Ltd.
Intravenous Solutions Market Dynamics

The key factors driving the demand for intravenous solutions are the prevalence of diseases like diabetes, gastrointestinal disorders, and neurological disorders resulting from an unhealthy lifestyle.


North-America Got Significant Share

Intravenous Solutions Market

The North American market is expected to witness the largest market share during the forecast period.

Latin America
Latin-America
North-America
North-America
Europe
Europe
Asia Pacific
Asia-Pacific
Middle East
Middle East
Intravenous Solutions Market Segmentation


Location

GEOGRAPHY

Frequently Asked Questions

The intravenous solutions market growing at a CAGR of 7.9% during 2022-28

The major players in the global intravenous solutions market are Baxter International Inc., ICU Medical, Inc., B. Braun Melsungen Ag, Grifols, S.A., Fresenius Kabi USA, LLC, Vifor Pharma Management Ltd., JW Life Science, Amanta Healthcare, Axa Parenterals Ltd., and Salius Pharma Private Limited.

North America is the fastest-growing region for intravenous solutions market


Report

Table Of Content

1. Executive Summary
2. Global Intravenous Solutions Market Introduction
2.1. Global Intravenous Solutions Market – Taxonomy
2.2. Global Intravenous Solutions Market –Definitions
2.2.1. By Solution Type
2.2.2. By Bag Type
2.2.3. By Application
3. Global Intravenous Solutions Market Dynamics
3.1. Drivers
3.2. Restraints
3.3. Opportunities/Unmet Needs of the Market
3.4. Trends
3.5. Global Intravenous Solutions Market Dynamic Factors – Impact Analysis
4. Global Intravenous Solutions Market Analysis,2017 – 2021 and Forecast, 2022 – 2028
4.1. Market Analysis,2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
4.2. Year-over-Year (Y-o-Y) Growth Analysis (%)
4.3. Market Opportunity Analysis
5. Global Intravenous Solutions Market, By Solution Type, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
5.1. Normal Saline (0.9% NaCl)
5.1.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
5.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.1.3. Market Opportunity Analysis
5.2. Hypertonic Saline
5.2.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
5.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.2.3. Market Opportunity Analysis
5.3. Dextran
5.3.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
5.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.3.3. Market Opportunity Analysis
5.4. Lactated Ringer’s
5.4.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
5.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.4.3. Market Opportunity Analysis
5.5. Amino Acid
5.5.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
5.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.5.3. Market Opportunity Analysis
5.6. Vitamins & Minerals
5.6.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
5.6.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.6.3. Market Opportunity Analysis
5.7. Heparin and Trace Elements
5.7.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
5.7.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.7.3. Market Opportunity Analysis
5.8. Mixed Solutions
5.8.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
5.8.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.8.3. Market Opportunity Analysis
6. Global Intravenous Solutions Market Forecast, By Bag Type, 2017 – 2021 and Forecast, 2020 – 2026 (Revenue, USD Mn)
6.1. Large Volume Bags
6.1.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
6.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.1.3. Market Opportunity Analysis
6.2. Small Volume Bags
6.2.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
6.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.2.3. Market Opportunity Analysis
7. Global Intravenous Solutions Market Forecast, By Application, 2017 – 2021 and Forecast, 2020 – 2026 (Revenue, USD Mn)
7.1. Basic IV Solution
7.1.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
7.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.1.3. Market Opportunity Analysis
7.2. Nutritional IV Solution
7.2.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
7.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.2.3. Market Opportunity Analysis
7.3. Blood IV Solution
7.3.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
7.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.3.3. Market Opportunity Analysis
7.4. Drug IV Solution
7.4.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
7.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.4.3. Market Opportunity Analysis
7.5. Irrigation IV Solution
7.5.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
7.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.5.3. Market Opportunity Analysis
8. Global Intravenous Solutions Market Forecast, By End-user, 2017 – 2021 and Forecast, 2020 – 2026 (Revenue, USD Mn)
8.1. Hospitals
8.1.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
8.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.1.3. Market Opportunity Analysis
8.2. Clinics
8.2.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
8.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.2.3. Market Opportunity Analysis
8.3. Ambulatory Surgery Centers
8.3.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
8.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.3.3. Market Opportunity Analysis
8.4. Home Care Settings
8.4.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
8.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.4.3. Market Opportunity Analysis
9. Global Intravenous Solutions Market Forecast, By Region, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
9.1. North America
9.1.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
9.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
9.1.3. Market Opportunity Analysis
9.2. Europe
9.2.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
9.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
9.2.3. Market Opportunity Analysis
9.3. Asia-Pacific
9.3.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
9.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
9.3.3. Market Opportunity Analysis
9.4. Latin America
9.4.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
9.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
9.4.3. Market Opportunity Analysis
9.5. Middle East and Africa
9.5.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
9.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
9.5.3. Market Opportunity Analysis
9.6. Global Intravenous Solutions Market – Opportunity Analysis Index, By Solution Type, By Bag Type, By Application, End-user and Region, 2022 – 2028
10. North America Intravenous SolutionsMarketAnalysis,2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
10.1. Solution Type Analysis 2017 – 2021 and Forecast 2022 – 2028by Revenue (USD Mn),Y-o-Y Growth (%), and Market Share (%)
10.1.1. Normal Saline (0.9% NaCl)
10.1.2. Hypertonic Saline
10.1.3. Dextran
10.1.4. Lactated Ringer’s
10.1.5. Amino Acid
10.1.6. Vitamins & Minerals
10.1.7. Heparin and Trace Elements
10.1.8. Mixed Solutions
10.2. Bag Type Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
10.2.1. Large Volume Bags
10.2.2. Small Volume Bags
10.3. Application Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
10.3.1. Basic IV Solution
10.3.2. Nutritional IV Solution
10.3.3. Blood IV Solution
10.3.4. Drug IV Solution
10.3.5. Irrigation IV Solution
10.4. End-user Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
10.4.1. Hospitals
10.4.2. Clinics
10.4.3. Ambulatory Surgery Centers
10.4.4. Home Care Settings
10.5. Country Analysis 2017 – 2021 and Forecast 2022 – 2028by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
10.5.1. USA
10.5.2. Canada
10.6. North America Intravenous Solutions Market – Opportunity Analysis Index, By Solution Type, By Bag Type, By Application and Country, 2022 – 2028
10.7. North America Intravenous Solutions Market Dynamics – Trends
11. Europe Intravenous Solutions Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
11.1. Solution Type Analysis 2017 – 2021 and Forecast 2022 – 2028by Revenue (USD Mn),Y-o-Y Growth (%), and Market Share (%)
11.1.1. Normal Saline (0.9% NaCl)
11.1.2. Hypertonic Saline
11.1.3. Dextran
11.1.4. Lactated Ringer’s
11.1.5. Amino Acid
11.1.6. Vitamins & Minerals
11.1.7. Heparin and Trace Elements
11.1.8. Mixed Solutions
11.2. Bag Type Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
11.2.1. Large Volume Bags
11.2.2. Small Volume Bags
11.3. Application Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
11.3.1. Basic IV Solution
11.3.2. Nutritional IV Solution
11.3.3. Blood IV Solution
11.3.4. Drug IV Solution
11.3.5. Irrigation IV Solution
11.4. End-user Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
11.4.1. Hospitals
11.4.2. Clinics
11.4.3. Ambulatory Surgery Centers
11.4.4. Home Care Settings
11.5. Country Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
11.5.1. Germany
11.5.2. UK
11.5.3. France
11.5.4. Spain
11.5.5. Italy
11.5.6. Russia
11.5.7. Poland
11.5.8. Rest of Europe
11.6. Europe Intravenous Solutions Market – Opportunity Analysis Index, By Solution Type, By Bag Type, By Application and Country,2022 – 2028
11.7. Europe Intravenous Solutions Market Dynamics – Trends
12. Asia-Pacific Intravenous Solutions Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
12.1. Solution Type Analysis 2017 – 2021 and Forecast 2022 – 2028by Revenue (USD Mn),Y-o-Y Growth (%), and Market Share (%)
12.1.1. Normal Saline (0.9% NaCl)
12.1.2. Hypertonic Saline
12.1.3. Dextran
12.1.4. Lactated Ringer’s
12.1.5. Amino Acid
12.1.6. Vitamins & Minerals
12.1.7. Heparin and Trace Elements
12.1.8. Mixed Solutions
12.2. Bag Type Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
12.2.1. Large Volume Bags
12.2.2. Small Volume Bags
12.3. Application Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
12.3.1. Basic IV Solution
12.3.2. Nutritional IV Solution
12.3.3. Blood IV Solution
12.3.4. Drug IV Solution
12.3.5. Irrigation IV Solution
12.4. End-user Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
12.4.1. Hospitals
12.4.2. Clinics
12.4.3. Ambulatory Surgery Centers
12.4.4. Home Care Settings
12.5. Country Analysis2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
12.5.1. Japan
12.5.2. China
12.5.3. India
12.5.4. ASEAN
12.5.5. Australia & New Zealand
12.5.6. Rest of Asia-Pacific
12.6. Asia-Pacific Intravenous Solutions Market – Opportunity Analysis Index, By Solution Type, By Bag Type, By Application and Country,2022 – 2028
12.7. Asia-Pacific Intravenous Solutions Market Dynamics – Trends
13. Latin America Intravenous Solutions Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
13.1. Solution Type Analysis 2017 – 2021 and Forecast 2022 – 2028by Revenue (USD Mn),Y-o-Y Growth (%), and Market Share (%)
13.1.1. Normal Saline (0.9% NaCl)
13.1.2. Hypertonic Saline
13.1.3. Dextran
13.1.4. Lactated Ringer’s
13.1.5. Amino Acid
13.1.6. Vitamins & Minerals
13.1.7. Heparin and Trace Elements
13.1.8. Mixed Solutions
13.2. Bag Type Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
13.2.1. Large Volume Bags
13.2.2. Small Volume Bags
13.3. Application Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
13.3.1. Basic IV Solution
13.3.2. Nutritional IV Solution
13.3.3. Blood IV Solution
13.3.4. Drug IV Solution
13.3.5. Irrigation IV Solution
13.4. End-user Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
13.4.1. Hospitals
13.4.2. Clinics
13.4.3. Ambulatory Surgery Centers
13.4.4. Home Care Settings
13.5. Country Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
13.5.1. Brazil
13.5.2. Mexico
13.5.3. Argentina
13.5.4. Rest of Latin America
13.6. Latin America Intravenous Solutions Market – Opportunity Analysis Index, By Solution Type, By Bag Type, By Application and Country,2022 – 2028
13.7. Latin America Intravenous Solutions Market Dynamics – Trends
14. Middle East and Africa Intravenous Solutions Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
14.1. Solution Type Analysis 2017 – 2021 and Forecast 2022 – 2028by Revenue (USD Mn),Y-o-Y Growth (%), and Market Share (%)
14.1.1. Normal Saline (0.9% NaCl)
14.1.2. Hypertonic Saline
14.1.3. Dextran
14.1.4. Lactated Ringer’s
14.1.5. Amino Acid
14.1.6. Vitamins & Minerals
14.1.7. Heparin and Trace Elements
14.1.8. Mixed Solutions
14.2. Bag Type Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
14.2.1. Large Volume Bags
14.2.2. Small Volume Bags
14.3. Application Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
14.3.1. Basic IV Solution
14.3.2. Nutritional IV Solution
14.3.3. Blood IV Solution
14.3.4. Drug IV Solution
14.3.5. Irrigation IV Solution
14.4. End-user Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
14.4.1. Hospitals
14.4.2. Clinics
14.4.3. Ambulatory Surgery Centers
14.4.4. Home Care Settings
14.5. Country Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
14.5.1. Gulf Cooperation Council (GCC) Countries
14.5.2. Israel
14.5.3. South Africa
14.5.4. Rest of MEA
14.6. MEA Intravenous Solutions Market – Opportunity Analysis Index, By Solution Type, By Bag Type, By Application and Country,2022 – 2028
14.7. MEA Intravenous Solutions Market Dynamics – Trends
15. Competition Landscape 
15.1. Strategic Dashboard of Top Market Players
15.2. Company Profiles (Introduction, Financial Analysis, Bag Type& Service Offerings, Key Developments, Strategies, and SWOT Analysis)
15.2.1. Baxter International Inc.
15.2.2. ICU Medical, Inc.
15.2.3. B. Braun Melsungen Ag
15.2.4. Grifols, S.A.
15.2.5. Fresenius Kabi USA, LLC
15.2.6. Vifor Pharma Management Ltd.
15.2.7. JW Life Science
15.2.8. Amanta Healthcare
15.2.9. Axa Parenterals Ltd.
15.2.10. Salius Pharma Private Limited.
16. Research Methodology
17. Key Assumptions and Acronyms

 


Report

Company Profile

  • Baxter International Inc.
  • ICU Medical, Inc.
  • B. Braun Melsungen Ag
  • Grifols, S.A.
  • Fresenius Kabi USA, LLC
  • Vifor Pharma Management Ltd.
  • JW Life Science
  • Amanta Healthcare
  • Axa Parenterals Ltd.
  • Salius Pharma Private Limited.

Description

Intravenous Solutions Market size was valued at USD 11.5 billion in 2021. It is expected to reach a value of USD 19.6 billion by 2028, growing at a CAGR of 7.9% during the forecast period from 2022 to 2028. The global market provides a detailed overview which has been segmented by solution type, bag type, application, and end user. By solution type, the intravenous solutions market has been segmented into Normal Saline (0.9% NaCl), Hypertonic Saline, Dextran, Lactated Ringer, Amino Acids, Vitamins and Minerals, Heparin and Trace Elements, and Mixed Solutions. The amino acid segment is likely the most significant and fastest-growing segment in terms of solution type. By Bag Type, the intravenous solutions market has been segmented into Large Volume Bags, Small Volume Bags. The small-volume bags segment gains the maximum revenue share in the market. By application, the intravenous solutions market has been segmented into Basic IV Solution, Nutritional IV Solution, Blood IV Solution, Drug IV Solution, and Irrigation IV Solution. The nutritional IV solution segment dominated the market in the forecast period 2022-2028. Based on the end user, the Intravenous Solutions are segmented into Hospitals, Clinics, Ambulatory Surgery Centers, and Home Care Settings. According to precision business insights, the hospital segment is predicted to register the fastest growth rate during the forecast period.

Key Development:

In February 2022, B. Braun Medical received the US FDA approval to begin operations at its new IV saline solution manufacturing facility in Daytona Beach, Florida.

Reviews

There are no reviews yet.

Be the first to review “Intravenous Solutions Market: Global Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis (2017-2021) and Forecast (2022-2028)”

Your email address will not be published. Required fields are marked *

ASIA PACIFIC OFFICE

Precision Business Insights, MIG 366, SAI PLAZA, 1st Floor, KPHB Colony, Hyderabad - 500072

EUROPE OFFICE

Precision Business Insights, Kemp House, 152 – 160 City Road, London EC1V 2NX